HS-20117 drug page Clinical trials

Trials with HS-20117

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
0Recruiting
1Countries
1.084Planned patients

Showing 1–2 of 2

A Phase Ib Study of HS-10370 in Addition to Other Anti-cancer Therapies in Patients With Advanced Solid Tumors
Not yet recruiting Phase 1 762 patients NCT06963502

This is a Phase Ib study that will evaluate the Safety, Tolerability , Pharmacokinetics, Activity and Immunogenicity of HS-10370 in Combination With Other Anti-cancer Therapies in Chinese patients with KRAS G12C mutation advanced or metast…

China May 2025 – Apr 2030 Interventional
A Phase I Clinical Study of HS-20117 in Participants With Advanced Solid Tumors
Not yet recruiting Phase 1 322 patients NCT05940116

HS-20117 is a fully-human EGFR-MET immunoglobulin G1(IgG1)-like bispecific antibody. The purpose of study is to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of HS-20117 as a monotherapy for participant…

China Jul 2023 – Jul 2027 Interventional